2026. Pharmacoeconomic Analysis of Cost Comparison Between Calcium Channel Blocker (CCB) and Angiotensin II Receptor Blocker (ARB) Antihypertensive Drugs in Hospitalized Hypertensive Patients at RSU Royal Prima. JURNAL FARMASIMED (JFM). 8, 2 (Apr. 2026), 1146–1155. DOI:https://doi.org/10.35451/y2fhvc35.